Valproate use in women of childbearing age: a study
Part of Mental health clinical trials.
This study explores how valproate—a medication sometimes used for psychiatric disorders—is prescribed to women who could become pregnant. Researchers want to understand current practices to improve safety.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 16 years old or older
- You are female
- You were prescribed valproate or a similar drug (like Divalproex, Valpromide, or Valproic Acid) for a psychiatric condition between January 1, 2021 and December 31, 2022
- You agree to let the researchers use your medical data after being told about the study (or your parent/guardian agrees if you are a minor)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at the Green Prescription program, which is a special health program for pregnant women. The goal is to see how well it works for women who are less than 32 weeks pregnant and speak French.
This trial studies how a person's genes affect their response to the epilepsy drug valproate. The goal is to find the best dose for each patient to improve seizure control and reduce side effects.
This study is for pregnant women with serious mental health conditions (like bipolar disorder or a psychotic disorder). It looks at how antipsychotic medications might affect both mothers and their babies, and aims to help guide safer treatment during pregnancy.
This study helps track how psychiatric (mental health) medicines affect pregnancy outcomes by collecting phone interviews during pregnancy. If you are pregnant and take (or have taken) mental health medication, you may help doctors understand risks and benefits better.
This trial studies whether adding a medicine called lamotrigine to valproate reduces seizures in children who haven’t fully stopped having seizures yet. It will also watch safety with lab tests and the child’s overall response.
This study measures how much epilepsy medicine (lamotrigine, levetiracetam, or oxcarbazepine) your body absorbs during pregnancy and breastfeeding. It may help doctors better understand dosing and safety during these times.
Hear when a new Psychiatric Disorder trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.